Pharmacologic considerations for cataract surgery.
PURPOSE OF REVIEW: A variety of options exist for perioperative, intraoperative, and postoperative medications in cataract surgery. This article reviews some of the more timely literature on "controversial" subjects in this area. RECENT FINDINGS: Recent literature may support the rationale for intracameral vancomycin at the time of cataract surgery. The recently released fluoroquinolones moxifloxacin and gatifloxacin are reviewed in terms of their clinical properties. Pharmacologic adjuncts to surgery are discussed, as is the use of intravitreal triamcinolone both at the time of cataract surgery and postoperatively. SUMMARY: Recent advances in ophthalmic pharmacology should aid the practicing anterior segment surgeon. This may affect preoperative, postoperative, and even intraoperative regimens.